Showcasing latest AI updates, Insilico Medicine attends 2024 EFMC International Symposium on Medicinal Chemistry
2024-08-30
(Press-News.org)
Attracting around 1,000 participants from industry and academia, the XXVIII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC) is supposed to take place in Rome, Italy from September 1-5, 2024. After the generative AI updates recently announced on the IMGAIA webinar, Insilico Medicine will be sharing more innovative details while exploring collaboration chances at Booth #50.
EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery, and the symposium this year features prizes and awards acknowledging the excellence of medicinal chemists’ work, as well as a wide coverage of selected topics including chemical biology, drug discovery projects, and technologies.
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) is an independent association founded in December 1969, representing 31 scientific organisations from 26 European countries, and more than 9000 scientists. By organizing symposia and short courses, sponsoring meetings and schools, and conferring awards, EFMC strives to establish links and to advance the science.
Founded in 2014, Insilico Medicine is a pioneer in using generative AI for drug discovery and development. Insilico first described the concept of using generative AI for the design of novel molecules in a peer-reviewed journal in 2016, which laid the foundation for the commercially available Pharma.AI platform spanning across biology, chemistry and clinical development. Powered by Pharma.AI, Insilico has nominated 18 preclinical candidates in its comprehensive portfolio of over 30 assets since 2021, and has received IND approval for 7 molecules. Recently, the company published a paper in Nature Biotechnology presenting the entire R&D journey of its lead drug pipeline, INS018_055, from AI algorithms to Phase II clinical trials.
About Insilico Medicine
Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.
www.insilico.com
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-08-30
COLUMBUS, Ohio – The invention of a tool capable of unlocking previously impossible organic chemical reactions has opened new pathways in the pharmaceutical industry to create effective drugs more quickly.
Traditionally, most drugs are assembled using molecular fragments called alkyl building blocks, organic compounds that have a wide variety of applications. However, because of how difficult it can be to combine different types of these compounds into something new, this method of creation ...
2024-08-30
Link to Google Drive folder containing images with caption and credit information:
https://drive.google.com/drive/folders/1UM9rl47Xd_Bs-ov0HpVwC-rtUDonM3oJ?usp=sharing
Post-embargo link to release:
https://www.washington.edu/news/2024/08/30/mosquito-swarm/
Embargoed by Current Biology
For public release at 11 a.m. U.S. Eastern Time (8 a.m. U.S. Pacific Time) on Friday, Aug. 30, 2024
A high-pitched buzzing sound in your ear is an unmistakable sign that a female mosquito is out on the hunt — for they, not males, drink blood. Hearing ...
2024-08-30
Many people who receive a problematic medical bill don’t challenge it – but new USC Schaeffer Center research shows they are likely missing out on a chance for financial relief.
About 1 in 5 people said they recently received a medical bill they disagreed with or couldn’t afford, including 61.5% who said they contacted a billing office to address their concern, according to survey results published Aug. 30 in JAMA Health Forum. Most who reached out said they received some form of payment help or had their bill corrected.
It’s ...
2024-08-30
Enrollment in Medicare Advantage (MA) plans is not associated with altered frailty trajectories compared with enrollment in Traditional Medicare (TM), according to research published today in JAMA Network Open.
In the article Frailty in Medicare Advantage Beneficiaries and Traditional Medicare Beneficiaries, lead author Sandra M. Shi, MD, MPH and colleagues suggest that more work is needed to better understand the health services needs of older adults with frailty.
“A growing proportion of the population is enrolling in Medicare Advantage (MA), which typically ...
2024-08-30
About The Study: This cohort study observed no significantly elevated long-term risk of autoimmune sequelae after SARS-CoV-2 Delta and Omicron BA.1 or BA.2 variant infection, except for a modestly increased risk of inflammatory bowel disease and bullous skin disorders in the hospitalized subgroup during the predominance of the Omicron variant. Booster vaccination appeared to mitigate the risk of long-term autoimmune sequelae.
Corresponding Author: To contact the corresponding author, Liang ...
2024-08-30
About The Study: The findings of this study suggest that racial disparities in cancer stage at diagnosis and survival exist among adolescent and young adult patients when disaggregated according to federal guidelines, which has health policy and funding implications. These results support the need for tailored interventions and informed public policy to achieve cancer care equity for all races.
Corresponding Author: To contact the corresponding author, Kekoa Taparra, MD, PhD, email ktaparra@stanford.edu.
To ...
2024-08-30
About The Study: This cohort study found that early childhood programming is associated with social determinants of health in adulthood. These findings reinforce the importance of early childhood education in addressing health disparities and contributing to healthier, more equitable communities and suggest that educational attainment is a key mechanism for health promotion.
Corresponding Author: To contact the corresponding author, Arthur J. Reynolds, PhD, email ajr@umn.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.32050)
Editor’s ...
2024-08-30
HER2 is a critical protein that plays a pivotal role in breast cancer cell growth and aggressiveness. Its expression level is a key indicator for treatment decisions, including the use of HER2-targeted therapies. Currently, HER2 status assessment relies heavily on immunohistochemical (IHC) staining of tissue slides followed by manual inspection by pathologists. This process, though widely adopted, suffers from several limitations, including poor reproducibility among pathologists and extended turnaround times. These challenges are further exacerbated in resource-constrained ...
2024-08-30
BUFFALO, NY- August 30, 2024 – A new editorial was published in Volume 11 of Oncoscience on July 19, 2024, entitled, “Functional information offers individualized adaptive cancer therapies.”
As introduced in this editorial, the Oxford Computer Science Dictionary offers both general and technical definitions of information. Generally, information is anything that can cause a change in a human mind's opinion about the current state of the real world. Technically, information is anything that reduces the uncertainty of a system's state. Claude Shannon provided an objective measure of information, known as entropy (H), by mathematically defining ...
2024-08-30
In a research paper, scientists from the Beijing Institute of Technology proposed an event related potential (ERP) extraction method to solve the asynchronous problem of low-quality video target detection, designed the time-frequency features based on continuous wavelet transform, and established an EEG decoding model based on neural characterization. The average decoding accuracy of 84.56% is achieved in pseudo-online test.
The new research paper, published July 4 in the journal Cyborg and Bionic Systems, introduces a low-quality ...
LAST 30 PRESS RELEASES:
[Press-News.org] Showcasing latest AI updates, Insilico Medicine attends 2024 EFMC International Symposium on Medicinal Chemistry
